Introduction
Iron (Fe) is an essential nutrient for
nearly all lifeforms due to its use as a cofactor in
numerous biochemical processes, including
oxidative phosphorylation, de novo DNA
synthesis, and nitrogen fixation, among others(1-
5). To harness the power of this element, iron
must first be acquired from the environment
before it can be biologically incorporated into
proteins and enzymes. For many organisms,
including most bacteria, the prevalent
environmental oxidation state of iron dictates its
mode of acquisition. For example, the highly
insoluble ferric iron (Fe
3+) is prevalent in oxic
environments, and bacteria will commonly
deploy siderophores to solubilize and to capture
this form of iron. Membrane receptors then
translocate the siderophore-chelated iron into the
cytosol, where the iron is either removed by
reductive dissociation or by cleavage of the
siderophore(6, 7). Additionally, some pathogenic
bacteria can sequester either free heme (iron
protoporphyrin IX) or utilize hemophores to
remove heme from host hemoproteins ( e.g.,
hemoglobin and myoglobin). Like siderophore-
mediated uptake, membrane receptors then
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
2
translocate the heme into the cytosol where the
heme is either recycled or destroyed to remove
the iron contained within(8-11). In contrast,
when living within anoxic or acidic
environments, bacteria commonly encounter the
more labile, but also more reactive, ferrous iron
(Fe
2+)(12-15). Unfortunately, despite its strong
contribution to bacterial metal homeostasis and
pathogenesis, the mechanisms of bacterial Fe 2+
acquisition are poorly understood compared to
the mechanisms of Fe 3+ uptake and heme
acquisition.
While some auxiliary Fe 2+ transport
systems have been identified, the fe rrous iro n
transport (Feo) system is the most widely
distributed and conserved Fe 2+ acquisition
system across the prokaryotic domain(12-15),
although Feo’s precise mechanism of function
remains unclear. Canonically, the feo operon
encodes for three proteins, FeoA, FeoB, and
FeoC(16), although FeoC is the least conserved
of these proteins(13-15, 17) (Fig. 1). FeoA and
FeoC are known to be small ( ca. 7-10 kDa)
cytosolic proteins, while FeoB is a large ( ca. 80-
100 kDa) polytopic transmembrane protein that
contains an N-terminal soluble G-protein-like
domain termed NFeoB(12, 14, 18). The roles of
FeoA and FeoC remain somewhat enigmatic;
however, these proteins have been shown to
interact with NFeoB in vitro(19), FeoA appears
to regulate GTP hydrolysis in vitro(17) , and
some FeoCs bind oxygen-sensitive [Fe-S]
clusters, presumably for regulatory purposes(20).
In vivo , several observations indicate that both
proteins interact with FeoB and are required for
Feo-dependent iron uptake in Vibrio cholerae
(Vc)(21, 22) , the pathogenic bacterium
responsible for the diarrheal disease cholera.
Interestingly, bacterial two hybrid (BACTH)
systems demonstrated that both VcFeoA and
VcFeoC were found to interact with intact
VcFeoB in the cell(23), although the precise
nature of this complex and its mechanism are
still unclear.
FeoB from V . cholerae was recently
shown to hydrolyze A TP, GTP, and other NTPs
in vitro, and this function could serve to supply V.
cholerae with Fe
2+ in vivo , indicating that this
FeoB may be better classified as an NTPase
rather than a strict GTPase(24, 25). This
promiscuity for NTP consumption was then
shown to occur in vitro for other FeoBs from a
handful of infectious bacterial species such as
Helicobacter pylori, Streptococcus mutans,
Staphylococcus aureus, and Bacillus cereus ,
which could suggest that NTP promiscuity may
be a common theme used by some pathogenic
bacteria to acquire iron and to establish infection.
NFeoB proteins contain generally conserved G-
motifs that are common amongst G-proteins and
are responsible for binding to different segments
of the guanine nucleotide, with G1, G2, and G3
binding to the α-, β-, and γ -phosphates, while
the G4 and G5 motifs interact with the
nucleobase(26). Sequence analyses suggested
that differentially conserved residues within the
G4 and G5 motifs might be important for
guanine recognition and for NTPase activity in
FeoB(27, 28). Specifically, the G5 motif
residues Ser148 and Asn150, when altered,
displayed significant effects on ATPase activity,
but minimal effects on GTPase activity,
indicating that these G5 residues may play a
critical role in nucleotide discrimination(24).
However, the structural basis of nucleotide
promiscuity in FeoB remained unknown,
precluding a more comprehensive understanding
of this unique aspect of the Feo system.
In this work, we have structurally and
biophysically characterized the VcNFeoB
domain in order to understand its nucleotide
promiscuity. Using X-ray crystallography, we
determined the structures of apo and GDP-
bound VcNFeoB, which reveals a conserved
NFeoB fold composed of a G-protein like
domain tethered to a GDI domain, despite the
nucleotide promiscuous nature of VcFeoB.
Additionally, we determined the X-ray crystal
structures of apo and GDP-bound N150T
VcNFeoB, and we show how differences in
residues at the G5 motif alter the hydrogen-
bonding interactions surrounding the guanine
nucleobase. Isothermal titration calorimetry
(ITC) was used to determine substrate affinities
and stoichiometries of different nucleotides to
both the wild-type and variant VcNFeoBs.
Intriguingly, we demonstrate dramatic
differences in the behavior of the VcNFeoB
towards GDP/GMP-PNP binding compared to
ADP/AMP-PNP binding, which could be
rationalized using AlphaFold modeling. Taken
together, these findings provide a structural
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
3
framework for understanding the nucleotide
promiscuity of VcFeoB, which could be
leveraged for future developments of targeted
therapeutics to tackle issues of V . cholerae
pathogenesis, as recently demonstrated(29).
Results
The VcNFeoB NTPase Domain Purifies as a
Nucleotide-Free Monomer that Displays Broad
NTPase Activity
To prepare the VcNFeoB NTPase domain
for crystallization trials, we overproduced in E.
coli a previously designed construct that encodes
for a non-cleavable (His)
6-tagged version of the
protein ( i.e., VcNFeoB(His)6))(24). As this
protein was not initially suitable for
crystallization from immobilized metal-affinity
chromatography (IMAC), we added two
additional purification steps: anion exchange
chromatography (AEX) and size-exclusion
chromatography (SEC), both of which revealed
interesting biophysical properties of
VcNFeoB(His)
6. First, regarding AEX, we
monitored the 260 nm / 280 nm ratio through the
entire chromatography process, and noted a
normal value of
≈ 0.6, indicating that
VcNFeoB(His)6 does not co-purify with
nucleotide, unlike previous reports of E. coli
NFeoB overproduced in E. coli(30) . Second,
SEC of either crudely purified VcNFeoB(His)6
(IMAC only) or polished VcNFeoB(His)6 (after
SEC) showed only the presence of a dominant
monomeric species in solution (Fig. S1),
consistent with our previous in vitro studies on
Feo proteins (from V . cholerae and others)
recombinantly produced in E. coli. It is possible
that FeoA and/or FeoC may be necessary to
induce FeoB oligomerization, and in vivo studies
have suggested this to be the case for Vibrio
cholerae(23). However, other Feo systems
appear to be functional monomers in vitro , and
this highly pure, monomeric Vc NFeoB(His)
6
domain was active against multiple nucleotide
triphosphates, most notably A TP and GTP, as
previously described(24), thus the precise
oligomeric state of FeoB remains controversial
and requires further exploration. For all
subsequent constructs ( vide infra ), a similar
overproduction and purification process was
employed, producing highly pure, homogeneous,
and monomeric protein (Fig. S1).
The Structure of the Apo VcNFeoB NTPase
Domain Reveals a Typical NFeoB Fold
In order to characterize the three
dimensional structure of the VcNFeoB NTPase
domain, we sought to crystallize the
VcNFeoB(His)
6 protein. Crystals of the apo
domain were generated and ultimately diffracted
to a modest 3.7 Å resolution in the P1 space
group consistent with 8 molecules (dimer of
tetramers) in the asymmetric unit (ASU) (Table
S1). This oligomerization is likely crystallization
induced based on our in-solution studies (Fig.
S1). We solved this structure by using molecular
replacement coupled with model building and
restrained refinement approaches ( R
w/Rf =
0.210/0.268) (Table S1), and an analysis of the
crystal contacts suggested that the (His) 6 tag
may have impacted the crystal quality. To
overcome this issue, VcNFeoB was recloned into
a vector encoding for N-terminal (His) 6 tag
fused to a cleavable SUMO moiety. Expression
and purification followed the same procedures
as previously described ( vide supra ), and the
SUMO tag was cleaved prior to crystallization.
Crystals of the SUMO-cleaved apo domain were
generated and ultimately diffracted to 2.3 Å
resolution in the P
121 space group consistent
with 2 molecules in the asymmetric unit (ASU)
(Table S1). This oligomerization is likely
crystallization induced based on our in-solution
studies (Fig. S1). Using the 3.7 Å resolution
model, we were able to solve the 2.3 Å
resolution structure of the tagless protein ( R
w/Rf
= 0.203/0.266) (Table S1).
The X-ray crystal structure of the apo
VcNFeoB NTPase domain reveals the presence
of a typical NFeoB fold (Fig. 2). Distinctly
present are the two common NFeoB
subdomains: the globular G-protein subdomain
that is responsible for binding and hydrolyzing
nucleotides (31) (Fig. 2, blue) and the hammer-
shaped guanine-dissociation inhibitor (GDI)
subdomain that regulates nucleotide dissociation
(32) and connects directly to the FeoB
transmembrane region (Fig. 2, red). Within the
G-protein domain, two switch regions (known as
Switch I and Switch II) that regulate nucleotide
hydrolysis and communicate nucleotide status to
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
4
the GDI domain (31, 32) are present, albeit
Switch I is mostly disordered, while Switch II is
mostly ordered in the apo form. Surprisingly,
comparison of the VcNFeoB NTPase domain to
other structurally characterized NFeoB domains
displays strong structural conservation in both
subdomains (C
α RMSD < 1Å on average) even
though the NFeoB is not a strict GTPase (Fig.
S2). These observations indicate that gross
structural changes in the NFeoB region do not
account for the observed nucleotide promiscuity
of V . cholerae FeoB per se.
The GDP-bound Structure of the VcNFeoB
NTPase Domain Reveals Important Nucleotide-
Binding Residues
To determine whether structural
properties within the nucleotide-binding pocket
could contribute to nucleotide promiscuity, we
sought to determine the structure of VcNFeoB in
the presence of various nucleotides. To do so, we
co-crystallized apo VcNFeoB (both SUMO-
cleaved and (His)
6 tagged) in the presence of
hydrolyzed nucleotides ( e.g., ADP and GDP)
and the presence of non- or slowly-hydrolyzable
triphosphate mimics (e.g., AMP-PNP, AMP-PCP,
and GMP-PNP). Despite extensive fine
screening and testing of multiple conditions, we
were only able to generate datasets of GDP-
bound VcNFeoB(His)
6 that diffracted modestly,
but completely, to 4.2 Å resolution in the C121
space group consistent with 4 molecules in the
asymmetric unit (ASU) (Table S1). This
oligomerization is likely crystallization induced
based on our in-solution studies (Fig. S1). Using
molecular replacement with our 2.3 Å apo
VcNFeoB structure coupled with strongly
restrained refinement approaches, we built a
model that clearly displayed GDP in the
nucleotide-binding pocket of all molecules in the
ASU based on omit maps (Fig. S3). Using the
X-ray structure of GDP-bound E. coli NFeoB as
a guide (PDB ID 3I8X; 2.3 Å resolution), we
were able to place GDP in all VcNFeoB
molecules in the ASU and to solve this structure
(R
w/Rf = 0.223/0.273) (Table S1).
The crystal structure of VcNFeoB(His)6
bound to GDP reveals multiple amino acids that
contribute to nucleotide binding (Fig. 3). In the
absence of nucleotide, the binding pocket is
fairly open, while binding of GDP elicits a
contraction surrounding the nucleobase with the
associated amino acids responsible for
nucleotide recognition coming together (Fig. S4).
In this structure, the Switch I loop that has been
shown to be important for GTP hydrolysis (31)
is mostly disordered, which may be attributed to
the flexibility of this region when GDP is bound.
As the nucleobase enters the binding pocket, a
region of random coil from Asn119 to Asp122
tightens (Fig. S4), and both residues (conserved
amongst NFeoBs) become within hydrogen-
bonding distance (3.5 and 2.8 Å, respectively) of
the guanine purine (Figs. 3,4a). Underneath the
guanine purine is Lys120, also conserved in
many NFeoBs, that appears to prop up the
hydrolyzed nucleotide in the binding pocket;
electrostatic contributions from this residue are
not observed in our structure, and in some
NFeoBs (like those in S. thermophilus, K.
pneumoniae, E. coli and Gallionella
capsiferriformans, and Thermotoga maritima )
this residue corresponds to a non-polar amino
acid, either a Met or an Ala(31, 33-36).
Interestingly, Asn150 is positioned along a
region of random coil (known as the G5 motif)
above the guanine purine but turned towards,
and tightly hydrogen bonded with Asp122 on the
G4 motif (2.3 Å distance) (Figs. 3,4a). Because
of the high variability within the G5 region, we
sought to use bioinformatics to gain a better
understanding of whether Asn150 might have an
important role in nucleotide discrimination.
Alterations in Hydrogen-Bonding Surrounding
the Nucleotide-Binding Pocket Are Likely Linked
To the Nucleotide Promiscuity of VcNFeoB
To gain a better understanding of
residues that are either conserved or variable
amongst NFeoB NTPases and GTPases, and to
understand whether these sequence differences
might contribute to functional differences, we
used multiple sequence analysis (MSA) and
phylogenetics. To do so, we limited our
approach only to the sequences that have been
previously tested in vitro to have either NTPase
or strictly GTPase activities(28). Partial
sequence alignments revealed that the position
analogous to Asn150 within the G5 motif of the
VcNFeoB NTPase domain is highly variable for
NFeoBs known to be NTPases, while this same
position is an invariant Thr residue for NFeoBs
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
5
known to be strict GTPases (Fig. 5A). The
flanking regions of the G5 motif are also highly
variable in NFeoB NTPases, while the same
regions are highly conserved in NFeoB GTPases
(Fig. 5A), suggesting that a degree of flexibility
near the nucleobase may be important for
nucleotide promiscuity. Intriguingly,
phylogenetic analyses using the full-length
sequences of bona fide FeoB NTPases and
GTPases reveal a differential clustering among
GTPase and NTPase proteins (Fig. 5B). While
the number of FeoB proteins with verified
nucleotide activity is low, this analysis could
suggest that convergent evolution (and/or
horizontal gene transfer) may have occurred
amongst these organisms, similar to a previous
hypothesis for the Feo system(13).
To test whether alteration of Asn150 to a
Thr residue would inform on structural changes
that may take place within the nucleotide-
binding pocket, we expressed, purified, and
crystallized the N150T variant of
VcNFeoB(His)
6 in the presence of GDP. The
crystals diffracted to 2.9 Å resolution (Table S1),
and initial analysis revealed one apo
VcNFeoB(His)6 NTPase domain and one GDP-
bound VcNFeoB(His)6 NTPase domain both
within the asymmetric unit. This hetero-
oligomerization is likely crystallization induced
based on our in-solution studies (Fig. S1). Omit
maps confirmed that substantial density was
present and consistent with GDP in one, but not
both, molecules within the asymmetric unit (Fig.
S3), allowing us to visualize a direct comparison
between the apo and the GDP-bound N150T
variant at the same resolution (Fig. 6).
Interestingly, the presence of Thr in position 150
affects the hydrogen bonding pattern
surrounding the guanine nucleobase both
directly and indirectly. First, the Thr hydroxyl
moiety now makes a new hydrogen bond with
position N1 along the purine ring (Fig. 4b).
Second, removal of Asn150 releases Asp122 to
tighten and to extend its hydrogen bonds with
positions N1 and the H
2N-C1 group (Fig. 4b).
Third, Asn119 appears to pull the guanine
further into the binding pocket, although
uncertainty due to modest resolution of the
GDP-bound WT Vc NFeoB NTPase domain
structure prevents a definitive statement
regarding Asn119 hydrogen bonding strength.
However, by comparison to the WT protein, the
N150T variant appears to have two key
additional hydrogen bonds surrounding the
guanine purine that could affect nucleotide
stability and may afford the discrimination of
GTP relative to other NTPs. Finally, like the WT
VcNFeoB NTPase domain, the N150T variant
displays a mostly disordered Switch I region and
a partially disordered Switch II region in both
the GDP-bound and apo forms.
Isothermal Titration Calorimetry Coupled with
AlphaFold Modeling Reveal Key Differences in
GTP/GDP and ATP/ADP Binding
To test the binding strength and binding
stoichiometry of various nucleotides to the WT
VcNFeoB NTPase domain and its N150T variant,
we used isothermal titration calorimetry (ITC)
(Fig. 7). Despite the hydrogen-bonding
differences in our X-ray crystal structures, the
WT and N150T Vc NFeoB proteins displayed
nearly identical binding strengths to GDP: WT
K
d of 3.18 μ M ± 0.23 μ M; N150T K d of 3.60
μ M ± 0.36 μ M (Fig. 7a,b) with a single binding
site (N ≈ 1). By comparison to the binding of
GMP-PNP (a non-hydrolyzable GTP analog),
the WT and N150T VcNFeoB constructs
displayed slightly different binding strengths,
consistent with our observed increase in
hydrogen bonding in the N150T variant: WT K
d
of 121.23 μ M ± 34.13 μ M; N150T K d of 93.95
μ M ± 15.63 μ M (Fig. 7c,d) with a single binding
site (N ≈ 1). GDP is known to have a stronger
affinity to NFeoBs than GTP/GMP-PNP due to
the presence and function of the GDI domain(32,
37), and we observed a similar trend as our
structural work also reveals the presence of a
GDI domain in Vc NFeoB. However, based on
these data, the presence/absence of Asn150
alone does not dramatically change the binding
strength of GTP/GDP to the VcNFeoB NTPase
domain. We then tested the ability of the
VcNFeoB NTPase domain to bind adenosine
containing nucleotides. While we attempted
multiple different concentrations and
stoichiometries using both hydrolyzed (ADP)
and non-hydrolyzable analogs (AMP-PNP), we
did not observe any appreciable saturation that
could be fitted to any logical binding isotherm
for both the WT and N150T variant proteins (Fig.
S5). However, titrations of ADP/AMP-PNP
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
6
showed strong amounts of heat evolution (up to
12 μ W per injection) even when corrected for
dilutions of nucleotide in the absence of protein
(Fig. S5). These observations suggest either a
rapid kinetic reversibility ( i.e., fast k
on and fast
koff), and/or a potential conformational change
that may be occurring as the domain samples
ADP/AMP-PNP in the binding pocket.
Finally, to gain a better understanding of
what may be occurring within the binding
pocket, we used the AlphaFold3 server to predict
the WT and N150T Vc NFeoB structures bound
to ADP and A TP (Fig. S6). Interestingly, in the
predicted WT structures in the presence of
adenine-containing nucleotides, Asn150 makes a
very weak interaction with the adenine purine
while Asp122 and Ser148 (part of the G4 and G5
motifs, respectively) turn completely away from
the binding pocket and make tight hydrogen-
bonds (
≈ 2.7 Å) with one another (Fig. S6a). A
similar result was observed in the N150T variant
with Thr150, making even weaker interactions
with the adenine nucleotide (Fig. S6b). In both
cases, strong hydrogen-bond interactions (
≤ 2.8
Å) with Ser148 cause the NTPase domain to
adopt an “Asp off” conformation, i.e. , Asp122
makes no interactions with the adenine
nucleobase. These results differ from the GDP-
bound structures, as both adopt a “Asp on”
conformation in which Asp122 makes strong
interactions (
≈ 2.4 Å – 2.8 Å) with the guanine
nucleobase. When we compare the ADP/A TP-
bound behavior to the apo structure of VcNFeoB
(Fig. S4), we note that the G4 and G5 regions
would need to undergo structural rearrangements
upon nucleotide binding, which could explain
the strong heat evolution upon ADP and AMP-
PNP titrations, but fewer hydrogen bonding
interactions likely preclude stable or prolonged
binding within the pocket, explaining the ITC
results.
Discussion
Whether FeoB, the primary prokaryotic
ferrous iron transporter, is nucleotide
promiscuous or nucleotide specific has
vacillated for some time. Before the structure of
NFeoB was known, early studies of FeoB
predicted that the protein might hydrolyze A TP
due to its sequence similarity to other A TPases,
and decreased FeoB-dependent iron uptake in
Helicobacter pylori was observed when A TP
synthesis was disrupted by proton
uncouplers(38-40). However, subsequent studies
of FeoB showed that the NFeoB domain from E.
coli was GTP-specific(41), and structures of
NFeoB from Methanocaldococcus jannaschii
and E. coli revealed the presence of a G-protein
like domain(34, 42), strongly implying that
NFeoB bound and hydrolyzed only guanine
nucleotides. This presumption continued for
nearly two additional decades, as additional
NFeoB structures were determined and FeoB
was further explored in an almost GTP-
exclusive manner(12, 14, 18). However, despite
this assumption, Shin et al reexamined NTPase
activity in the context of V . cholerae FeoB and
found this protein to be nucleotide promiscuous
both in vitro and in vivo(24). These observations
were further expanded to show that several
bacterial FeoBs could be differentially classified
as GTP-specific while others could be classified
as nucleotide promiscuous(24, 25). However, the
structural basis for this functional divergence of
FeoB was not known.
In this work, we provided the first X-ray
crystal structure of V . cholerae NFeoB, a notably
promiscuous NTPase, in its WT and variant
forms, both in the presence and absence of
nucleotides. While the general NFeoB G-protein
like fold is conserved in our structures, the GDP-
bound WT Vc NFeoB(His)
6 structure revealed
interactions between Asn150 (G5 motif) and
Asp122 (G4 motif) that caused Asp122 to
decrease the number of interactions it makes
with the guanine nucleobase. As Asn150 is
highly variable among NFeoB NTPases but
conserved as a Thr among NFeoB GTPases, we
wondered whether alteration of this residue
alone could change nucleotide binding strength
and/or specificity. Our structure of N150T
VcNFeoB(His)
6 revealed increased H-bonding to
the nucleobase due to the presence of Thr150 in
the G5 motif, but this modification alone did not
dramatically alter the binding affinity between
NFeoB and GDP and only modestly increased
the binding affinity between NFeoB and GMP-
PNP. Instead, we hypothesized that the observed
altered interactions might contribute more to
nucleotide promiscuity.
While we were unable to determine
experimental structures of adenine-based
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
7
nucleotides bound to Vc NFeoB, ITC data and
AlphaFold modeling provided insight into
nucleotide promiscuity when taken in context of
our other experimentally-determined structures.
For example, ITC analyses of ADP- or AMP-
PNP titrated into VcNFeoB revealed an isotherm
that failed to saturate but displayed strong heat
evolution even after correction for appropriate
dilutions, distinct from the response of this
domain in the presence of GDP and GMP-PNP.
This unusual behavior could be interpreted to
mean weak binding but also that conformational
changes may accompany the interactions of
ADP/AMP-PNP within the nucleotide binding
pocket, perhaps explaining why we failed to
produce crystals of adenosine nucleotides bound
to VcNFeoB despite exhaustive trials. Structural
modeling using AlphaFold supports this notion,
as predicted structures of both ADP- and ATP-
bound VcNFeoB revealed movement of the G4
Asp122 residue and G5 Ser148 residue to lock
the two amino acids into a strong H-bond
preventing Asp122 from interacting with the
nucleobase (i.e., “Asp off”). This conformational
change opens up the binding pocket and results
in only weak interactions as ADP/A TP enters but
then exits the domain, likely rapidly. However,
the rate of this conformational change must be
slower than the rate of ATP hydrolysis, as we
note that VcNFeoB still hydrolyzes A TP robustly
under these conditions(24, 25). In fact, all three
residues (Asp122, Ser148, and Asn150)
combined displayed an important role for ATP
hydrolysis(24), suggesting the G4 and G5 motif
are working in concert to contribute to
nucleotide specificity.
Interestingly, structural analyses of other
bacterial NTPases reveal a similar amino acid
pattern that may contribute to a more general
nucleotide promiscuity (Fig. S7), which could be
leveraged for a functional advantage by select
organisms. For example, among these NTPases
in the G5 motif position analogous to Asn150 in
VcNFeoB are a diverse set of amino acids that
only interact with the nucleotide base weakly at
best(43), but this weak interaction may be
important for plasticity within the binding
pocket. In contrast, the positions analogous to
Asp122 and Ser148 in Vc NFeoB are conserved
in these other bacterial NTPases. Conservation
of Asp in this region is unsurprising, as the G4
NxxD motif is required for GTP hydrolysis(44),
but Ser is not; it may be possible that the Ser
residue is needed to stabilize the “Asp off”
conformation for NTPases to facilitate
promiscuity in general. Based on these
observations, we propose that a combination of
these three amino acids in G4 and G5 provide
conformational flexibility to allow the utilization
of both GTP and A TP for protein function. In the
case of FeoB, it is possible that this nucleotide
promiscuity may provide an advantage to the
several bacterial pathogens that are NTP
agnostic. For these organisms, we propose that
FeoB could leverage ATP hydrolysis when GTP
levels in the cell are low, perhaps as a virulence
factor or another adaptive mechanism to ensure
Fe
2+ uptake across a wide array of conditions,
given iron’s essential nature to bacterial function.
However, under homeostatic conditions, NTP
promiscuous FeoBs likely rely on GTP and are
likely still regulated by GDP based on the stable
interactions observed in this study. Moreover,
given the highly reactive nature of its
translocated substrate, regulation of FeoB-
mediated Fe
2+ uptake by the status of GDP/GTP
is presumably an important protective
mechanism to prevent iron overload within the
cell. It is possible that this intriguing mechanism
of FeoB function could be leveraged as a means
to combat bacterial virulence in the future.
EXPERIMENTAL PROCEDURES
Cloning of NFeoB Constructs
The VcNFeoB(His)
6 WT and N150T
variant constructs were cloned into the pET-
21a(+) plasmid as described previously (24)
based on the sequence of WT VcFeoB (Uniprot
ID C3LP27). To create the N-terminal (His)
6-
SUMO-VcNFeoB fusion, the gene encoding for
VcNFeoB was subcloned, and a synthetically
added sequence for the Small Ubiquitin-like
Modifier (SUMO) protein (Uniprot ID Q12306)
was commercially appended (GenScript). The
entire sequence was then subcloned into the
pET-45b(+) plasmid between the Pml I and Pac I
restriction sites, which allows for the translation
of the N-terminal (His)
6-SUMO-VcNFeoB
fusion when read in frame.
Expression of NFeoB Constructs
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
8
The VcNFeoB(His)6 WT and N150T
variant plasmids were separately transformed
into BL21(DE3) electrocompetent cells via
electroporation, plated on Luria-Bertani (LB)
plates supplemented with ampicillin (100
μg/mL), and incubated at 30 ºC overnight. The
next day, starter flasks containing 100 mL LB
broth and am picillin (100 μ g/mL) were
inoculated with a single colony each (WT and
N150T) and allowed to grow overnight at 30 ºC
with 200 RPM shaking. The next day, 25 mL of
the overnight cultures were inoculated into 1 L
flasks charged with 1 L LB broth and ampicillin
(100 μg/mL, final), and these cells were grown
at 37 ºC with shaking of 200 RPM. When OD
600
reached 0.4-0.8, the cells in the flasks were then
cold shocked at 4 ºC for 2 h before induction
with isopropyl β -D-1-thiogalactopyranoside
(IPTG) to a final concentration of 1 mM. Cells
were then grown for ca. 20 h overnight and
harvested the next day by spinning at 5000 x g,
resuspended in resuspension buffer (50 mM Tris
pH 8.0, 300 mM NaCl, and 10 % (v/v) glycerol)
before being flash frozen on N 2(l) and stored at -
80 ºC.
All purification steps were conducted at
4 ºC unless otherwise stated. Frozen cells were
thawed and diluted to 100 mL with resuspension
buffer, and 1 mM (final) phenylmethylsulfonyl
fluoride (PMSF) was added prior to sonication at
80 % amplitude, 30 s on pulse, 30 s rest pulse,
12 min total. Lysed cells were clarified by
spinning at 163,000 x g for 1 h. The supernatant
was then applied to a 5 mL HisTrap HP column
(Cytiva) that was pre-charged with Ni
2+ and
equilibrated with 5 column volumes (CVs) of
wash buffer (50 mM Tris pH 8.0, 300 mM NaCl,
10 % (v/v) glycerol and 1 mM TCEP). After the
sample was applied, the column was washed
with 10 CVs of wash buffer, then with wash
buffer containing 50 mM imidazole, and eluted
with wash buffer containing 150 mM imidazole.
Eluted protein fractions were then pooled, and
buffer exchanged into ion exchange wash buffer
(50 mM Tris pH 8, 10 % (v/v) glycerol) using a
50 mL HiPrep 26/10 desalting column to remove
all salt content before anion exchange
chromatography. After desalting, the protein was
then applied to a 5 mL HiTrap Q HP anion
exchange column (Cytiva) that was then washed
extensively with 10 CVs of the ion exchange
buffer. The protein was purified via a linear
elution gradient from 0 M to 1 M NaCl. Eluted
protein fractions were pooled, concentrated via a
10 kDa molecular weight cutoff (MWCO) filter,
and injected onto a 120 mL Superdex 75
preparative grade gel filtration column (Cytiva)
after equilibration with 1.5 CVs of size
exclusion buffer (25 mM Tris pH 8.0, 100 mM
NaCl, 5 % (v/v) glycerol and 1 mM TCEP).
Fractions corresponding to pure, monomeric
VcNFeoB(His)
6 were pooled and concentrated
via a 10 kDa MWCO filter to ca. 12 mg/mL,
aliquoted, flash frozen on N 2(l) and stored at -80
ºC. An identical procedure was followed for the
VcNFeoB(His)
6 N150T variant.
The cellular transformation, expression,
cellular harvesting, cellular lysis, and initial
Ni
2+-based purification of the (His) 6-SUMO-
VcNFeoB mirrored that of VcNFeoB(His)6.
After fractions were eluted from the 5 mL
HisTrap HP column, the (His) 6-SUMO-
VcNFeoB protein was buffer exchanged into
SUMO cleavage buffer (50 mM Tris pH 8.0, 300
mM NaCl, 10 % (v/v) glycerol, and 10 mM β -
mercaptoethanol (BME)) and concentrated via a
10 kDa MWCO filter. House-made SUMO
protease Ulp1 was then added at a 1:100
(mg/mg) ratio and allowed to cleave overnight
with gentle rocking at 4 ºC. The next day, the
solution was applied again to a 5 mL HisTrap
HP column to separate the now cleaved
VcNFeoB from any uncleaved protein. Eluted
fractions containing cleaved VcNFeoB were
concentrated via a 10 kDa MWCO filter injected
onto a 120 mL preparative Superdex 75 column,
eluted isocratically, pooled, and stored
identically to VcNFeoB(His)
6 (vide supra).
Crystallization of NFeoB Constructs
Apo VcNFeoB(His)6 was initially
thawed and diluted to 10 mg/mL with size
exclusion buffer prior to crystallization trials.
Several commercial sparse-matrix screens were
used to test for crystallization using vapor
diffusion in sitting drop format. After incubation
at 25 ºC for ca. 4 months, crystals appeared in a
condition containing 25 % (w/v) PEG 3350, 0.1
M bis-Tris pH 5.5, and 0.2 M MgCl
2. The
crystals were then looped, cryo-protected, and
frozen in N
2(l). Unfortunately, fine screens failed
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
9
to replicate crystallization for further
optimization.
To crystallize GDP-bound
VcNFeoB(His)6, protein at 10 mg/mL was
incubated with 3 mM GDP for 2 h at room
temperature before sparse-matrix screens were
used to test for crystallization using vapor
diffusion in sitting drop format at 25 ºC. After 2
weeks, small, cubic-shaped crystals appeared in
a condition containing 25 % (w/v) PEG 3350,
0.1 M bis-Tris pH 5.5, 0.2 M MgCl
2, and 0.1 M
LiCl. Crystals were then looped, cryo-protected,
and frozen in N
2(l).
The preparation of GDP-bound
VcNFeoB(His)
6 N150T was identical to that of
the WT protein. Sparse-matrix screens were
used to test for crystallization using vapor
diffusion in sitting drop format at 25 ºC. Crystals
initially appeared in conditions containing 24 %
(w/v) PEG 3350, 0.1 M bis-Tris pH 5.5, 0.03 M
MgCl
2, and 0.2 M (NH 4)2SO4. Crystals matured
after two weeks and were then looped, cryo-
protected, and frozen in N
2(l).
To crystallize SUMO-cleaved VcNFeoB,
the protein was initially thawed and incubated
with 3 mM ADP prior to dilution to 10 mg/mL.
Sparse-matrix screens were used to test for
crystallization using vapor diffusion in sitting
drop format at 20 ºC. After two weeks of
incubation, clustered crystals appeared in a
condition containing 30 % (w/v) PEG 2000, 0.1
M Tris pH 8.0. Single crystals were separated
manually using crystallization tools after the
clusters were transferred to a drop containing
cryo-protectant. Separated single crystals were
then looped and frozen in N
2(l).
X-ray Diffraction, Data Reduction, and
Structural Determination
Diffraction data were collected at the
Advanced Photon Source (APS), Argonne
National Laboratory on LS-CAT beamline 21-
ID-D and at Brookhaven National Laboratory
beamline 17-ID-2 (FMX). Data were
automatically processed using Xia2 (45) and/or
AutoProc(46). The initial phases of all datasets
were determined by molecular replacement
(MR) using Phenix Phaser (47) with an
AlphaFold-generated model as an initial search
input(48). After an initial MR solution was
identified, further model building was
accomplished using Phenix AutoBuild(47). The
unambiguous presence of GDP in the
nucleotide-binding site was confirmed by the
generation of Polder maps in Phenix for GDP-
bound VcNFeoB(His)
6 WT and N150T datasets.
The initial placement of GDP was determined
based on the structure of E. coli NFeoB bound to
GDP (PDB ID 3I8X) that was then further
refined. Iterative rounds of manual model
building and refinement were accomplished in
Coot (49) and Phenix Refine(47), respectively,
until model convergence and the final placement
of any visible solvent molecules. Ramachandran
statistics and clash values were determined from
the MolProbity program (50) within the Phenix
software suite. The following structures have
been deposited in the Protein Data Bank: WT
apo VcNFeoB(His)
6 (PDB ID 8VWL); WT
GDP-bound VcNFeoB(His)6 (PDB ID 8VWN);
N150T GDP-bound Vc NFeoB(His)6 (PDB ID
9BA7); SUMO-cleaved apo VcNFeoB (PDB ID
9BA6). Data collection and refinement statistics
are provided for all structures in SI Table 1.
Isothermal Titration Calorimetry
Purified WT or N150T Vc NFeoB(His)6
was diluted to 0.1 mM (3.2 mg/mL) in SEC
buffer for all isothermal titration calorimetry
(ITC) experiments. Experiments were conducted
using the MicroCal PEAQ-ITC Automated
(Malvern Panalytical) to probe nucleotide
binding. All titrations with nucleotide
diphosphates (GDP and ADP) were performed in
25 mM Tris pH 8.0, 100 mM NaCl, 5% (v/v)
glycerol and 1 mM TCEP, while experiments
involving the triphosphate mimics (GMP-PNP
and AMP-PNP) were conducted using the same
buffer conditions except with added MgCl
2 to 10
mM final concentration. The calorimetry cell
was loaded with 200 μ L of WT or N150T
VcNFeoB(His)6, and 40 μ L of nucleotide (GDP,
GMP-PNP, ADP, or AMP-PNP) at 2.5 mM
concentration (GDP and GMP-PNP) or 5.0 mM
concentration (ADP and AMP-PNP) was loaded
into the injection syringe. Thermal equilibrium
was reached at 25 ºC after an initial 60 s delay
followed by 19X 2
μ L serial injections into the
cell with 150 s interval delays between injection
points with high spinning. Data were analyzed
using the Malvern MicroCal PEAQ ITC analysis
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
10
tool and fitted to a binding isotherm that has a
single site using the following equations:
Equation 1:
∆/g1843 /g4666 /g1861 /g4667 /g3404/g1843 /g4666 /g1861 /g4667 /g3397 /g1856/g1848 /g3036
/g1848 /g3042
/g4680 /g1843 /g4666 /g1861 /g4667 /g3397/g1843 /g4666 /g1861/g33981 /g4667
2 /g4681/g3398/g1843 /g4666 /g1861/g33981 /g4667
Where the heat released, ∆ Q(i), from the ith
injection is represented by ∆ Q(i).
Equation 2
:
/g1843/g3404/g1866 Θ /g1839 /g3047Δ/g1834/g1848 /g2868
Where the total heat (Q) is related to the number
of sites (n), the fractional occupation (
Θ ) the
total free concentration of the macromolecule
(Mt), the molar heat of ligand binding ( Δ H), and
the volume determined relative to zero for the
unbound species (V0).
Bioinformatic Analyses
Based on previous studies in which
nucleotide promiscuity of NFeoB from multiple
organisms was initially uncovered(28),
sequences were obtained from the Uniprot
database of intact FeoBs. A multiple sequence
alignment was constructed through the EMBL
MUSCLE program using default
parameters(51). The resultant alignment was
visualized via Jalview (52-54) and was then
entered into the MEGAX software (55-57) for
phylogenetic analysis using the maximum
likelihood method and 500 bootstrap iterations
with a minimum coverage of 95%. The final
phylogenetic results were also visualized using
MEGAX.
Structural prediction using AlphaFold3
Predicted VcNFeoB structures with
adenosine nucleotides (ATP and ADP) were
generated using the AlphaFold3 (58) server by
submitting amino acids 1-261 from VcFeoB
(Uniprot ID C3LP27) with either ADP and Mg
2+
or ATP and Mg 2+ and utilizing the default
parameters. In all cases, the lowest energy
calculated structure is displayed as being
representative, but the resulting five calculated
structures for each prediction reveal very similar
results. The calculated structures were both
visualized and analyzed using ChimeraX(59).
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
11
References
1. Steimle, S., van Eeuwen, T., Ozturk, Y ., Kim, H. J., Braitbard, M., Selamoglu, N. et al.
(2021) Cryo-EM structures of engineered active bc1-cbb1 type CIII2CIV super-complexes
and electronic communication between the complex Nat Commun 12, 929
10.1038/s41467-021-21051-4
2. Booker, S., Broderick, J., and Stubbe, J. (1993) Ribonucleotide reductases: radical
enzymes with suicidal tendencies Biochem Soc Trans 21 ( Pt 3), 727-730
10.1042/bst0210727
3. Glorieux, C., and Calderon, P. B. (2017) Catalase, a remarkable enzyme: targeting the
oldest antioxidant enzyme to find a new cancer treatment approach Biol Chem 398, 1095-
1108 10.1515/hsz-2017-0131
4. Einsle, O., and Rees, D. C. (2020) Structural Enzymology of Nitrogenase Enzymes Chem
Rev 120, 4969-5004 10.1021/acs.chemrev.0c00067
5. Hu, Y ., and Ribbe, M. W. (2015) Nitrogenase and homologs J Biol Inorg Chem 20, 435-
445 10.1007/s00775-014-1225-3
6. Schalk, I. J., and Mislin, G. L. A. (2017) Bacterial Iron Uptake Pathways: Gates for the
Import of Bactericide Compounds J Med Chem 60, 4573-4576
10.1021/acs.jmedchem.7b00554
7. Cain, T. J., and Smith, A. T. (2021) Ferric iron reductases and their contribution to
unicellular ferrous iron uptake J Inorg Biochem 218, 111407
10.1016/j.jinorgbio.2021.111407
8. Choby, J. E., and Skaar, E. P . (2016) Heme Synthesis and Acquisition in Bacterial
Pathogens J Mol Biol 428, 3408-3428 10.1016/j.jmb.2016.03.018
9. Skaar, E. P. (2010) The Battle for Iron between Bacterial Pathogens and Their Vertebrate
Hosts PloS Pathogens 6, 1-4 10.1371/journal. ppat.1000949
10. Smith, A. D., and Wilks, A. (2015) Differential contributions of the outer membrane
receptors PhuR and HasR to heme acquisition in Pseudomonas aeruginosa J Biol Chem
290, 7756-7766 10.1074/jbc.M114.633495
11. Cescau, S., Cwerman, H., Létoffé, S., Delepelaire, P., Wandersman, C., and Biville, F.
(2007) Heme acquisition by hemophores Biometals 20, 603-613 10.1007/s10534-006-
9050-y
12. Brown, J. B., Lee, M. A., and Smith, A. T. (2021) Ins and Outs: Recent Advancements in
Membrane Protein-Mediated Prokaryotic Ferrous Iron Transport Biochemistry
10.1021/acs.biochem.1c00586
13. Gómez-Garzón, C., Barrick, J. E., and Payne, S. M. (2022) Disentangling the
Evolutionary History of Feo, the Major Ferrous Iron Transport System in Bacteria mBio
13, e0351221 10.1128/mbio.03512-21
14. Sestok, A. E., Linkous, R. O., and Smith, A. T. (2018) Toward a mechanistic
understanding of Feo-mediated ferrous iron uptake Metallomics 10, 887-898
10.1039/c8mt00097b
15. Lau, C. K., Krewulak, K. D., and V ogel, H. J. (2016) Bacterial ferrous iron transport: the
Feo system FEMS Microbiol Rev 40, 273-298 10.1093/femsre/fuv049
16. Hantke, K. (1987) Ferrous iron transport mutants in E scherichia coli K12 FEMS
Microbiology Letters 44, 53-57 https://doi.org/10.1111/j.1574-6968.1987.tb02241.x
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
20
17. Sestok, A. E., Brown, J. B., Obi, J. O., O'Sullivan, S. M., Garcin, E. D., Deredge, D. J. et
al. (2022) A fusion of the Bacteroides fragilis ferrous iron import proteins reveals a role
for FeoA in stabilizing GTP-bound FeoB J Biol Chem 298, 101808
10.1016/j.jbc.2022.101808
18. Sestok, A. E., Lee, M. A., and Smith, A. T. (2020) Prokaryotic ferrous iron uptake:
exploiting pools of reduced iron across multiple microbial environments. In Advances in
Environmental Microbiology: Microbial Metabolism of Metals and Metalloids, Hurst CJ,
ed.
19. Brown, J. B., Lee, M. A., and Smith, A. T. (2022) The structure of Vibrio cholerae FeoC
reveals conservation of the helix-turn-helix motif but not the cluster-binding domain J
Biol Inorg Chem 27, 485-495 10.1007/s00775-022-01945-4
20. Smith, A. T., Linkous, R. O., Max, N. J., Sestok, A. E., Szalai, V . A., and Chacón, K. N.
(2019) The FeoC [4Fe-4S] Cluster Is Redox-Active and Rapidly Oxygen-Sensitive
Biochemistry 58, 4935-4949 10.1021/acs.biochem.9b00745
21. Weaver, E. A., Wyckoff, E. E., Mey, A. R., Morrison, R., and Payne, S. M. (2013) FeoA
and FeoC are essential components of the Vibrio cholerae ferrous iron uptake system, and
FeoC interacts with FeoB J Bacteriol 195, 4826-4835 10.1128/JB.00738-13
22. Faruque, S. M., Albert, M. J., and Mekalanos, J. J. (1998) Epidemiology, genetics, and
ecology of toxigenic Vibrio cholerae Microbiol Mol Biol Rev 62, 1301-1314
10.1128/MMBR.62.4.1301-1314.1998
23. Stevenson, B., Wyckoff, E. E., and Payne, S. M. (2016) Vibrio cholerae FeoA, FeoB, and
FeoC Interact To Form a Complex J Bacteriol 198, 1160-1170 10.1128/JB.00930-15
24. Shin, M., Mey, A. R., and Payne, S. M. (2019) FeoB contains a dual nucleotide-specific
NTPase domain essential for ferrous iron uptake Proc Natl Acad Sci U S A 116, 4599-
4604 10.1073/pnas.1817964116
25. Gómez-Garzón, C., and Payne, S. M. (2020) FeoB hydrolyzes A TP and GTP Metallomics
12, 2065-2074 10.1039/d0mt00195c
26. Luo, M., Han, Z., Huang, G., Li, R., Liu, Y ., Lu, J. et al. (2022) Structural comparison of
unconventional G protein YchF with heterotrimeric G protein and small G protein Plant
Signal Behav 17, 2024405 10.1080/15592324.2021.2024405
27. Osaka, N., Hirota, Y ., Ito, D., Ikeda, Y ., Kamata, R., Fujii, Y . et al. (2021) Divergent
Mechanisms Activating RAS and Small GTPases Through Post-translational
Modification Front Mol Biosci 8, 707439 10.3389/fmolb.2021.707439
28. Shin, M., Park, J., Jin, Y ., Kim, I. J., Payne, S. M., and Kim, K. H. (2020) Biochemical
characterization of bacterial FeoBs: A perspective on nucleotide specificity Arch
Biochem Biophys 685, 108350 10.1016/j.abb.2020.108350
29. Shin, M., Jin, Y ., Park, J., Mun, D., Kim, S. R., Payne, S. M. et al. (2021)
Characterization of an antibacterial agent targeting ferrous iron transport protein FeoB
against Staphylococcus aureus and Gram-positive bacteria ACS Chem Biol 16, 136-149,
30. Hagelueken, G., Hoffmann, J., Schubert, E., Duthie, F. G., Florin, N., Konrad, L. et al.
(2016) Studies on the X-Ray and Solution Structure of FeoB from Escherichia coli BL21
Biophys J 110, 2642-2650 10.1016/j.bpj.2016.05.018
31. Ash, M. R., Maher, M. J., Guss, J. M., and Jormakka, M. (2011) A suite of Switch I and
Switch II mutant structures from the G-protein domain of FeoB Acta Crystallogr D Biol
Crystallogr 67, 973-980 10.1107/S0907444911039461
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
21
32. Eng, E. T., Jalilian, A. R., Spasov, K. A., and Unger, V . M. (2008) Characterization of a
novel prokaryotic GDP dissociation inhibitor domain from the G protein coupled
membrane protein FeoB J Mol Biol 375, 1086-1097 10.1016/j.jmb.2007.11.027
33. Hung, K. W., Chang, Y . W., Eng, E. T., Chen, J. H., Chen, Y . C., Sun, Y . J. et al. (2010)
Structural fold, conservation and Fe(II) binding of the intracellular domain of prokaryote
FeoB J Struct Biol 170, 501-512 10.1016/j.jsb.2010.01.017
34. Guilfoyle, A., Maher, M. J., Rapp, M., Clarke, R., Harrop, S., and Jormakka, M. (2009)
Structural basis of GDP release and gating in G protein coupled Fe2+ transport EMBO J
28, 2677-2685 10.1038/emboj.2009.208
35. Deshpande, C. N., McGrath, A. P ., Font, J., Guilfoyle, A. P., Maher, M. J., and Jormakka,
M. (2013) Structure of an atypical FeoB G-domain reveals a putative domain-swapped
dimer Acta Crystallogr Sect F Struct Biol Cryst Commun 69, 399-404
10.1107/S1744309113005939
36. Hattori, M., Jin, Y ., Nishimasu, H., Tanaka, Y ., Mochizuki, M., Uchiumi, T. et al. (2009)
Structural basis of novel interactions between the small-GTPase and GDI-like domains in
prokaryotic FeoB iron transporter Structure 17, 1345-1355 10.1016/j.str.2009.08.007
37. Petermann, N., Hansen, G., Schmidt, C. L., and Hilgenfeld, R. (2010) Structure of the
GTPase and GDI domains of FeoB, the ferrous iron transporter of Legionella
pneumophila FEBS Lett 584, 733-738 10.1016/j.febslet.2009.12.045
38. Hantke, K. (1987) Ferrous iron transport mutants in E scherichia coli K12 FEMS
Microbiol Lett 44, 53-57 10.1111/j.1574-6968.1987.tb02241.x
39. Kammler, M., Schön, C., and Hantke, K. (1993) Characterization of the ferrous iron
uptake system of Escherichia coli J Bacteriol 175, 6212-6219 10.1128/jb.175.19.6212-
6219.1993
40. Velayudhan, J., Hughes, N. J., McColm, A. A., Bagshaw, J., Clayton, C. L., Andrews, S.
C. et al. (2000) Iron acquisition and virulence in Helicobacter pylori: a major role for
FeoB, a high-affinity ferrous iron transporter Mol Microbiol 37, 274-286 10.1046/j.1365-
2958.2000.01987.x
41. Marlovits, T. C., Haase, W., Herrmann, C., Aller, S. G., and Unger, V . M. (2002) The
membrane protein FeoB contains an intramolecular G protein essential for Fe(II) uptake
in bacteria Proc Natl Acad Sci U S A 99, 16243-16248 10.1073/pnas.242338299
42. Köster, S., Wehner, M., Herrmann, C., Kühlbrandt, W., andYildiz, O. (2009) Structure
and function of the FeoB G-domain from Methanococcus jannaschii J Mol Biol 392, 405-
419 10.1016/j.jmb.2009.07.020
43. Vaccaro, F. A., and Drennan, C. L. (2022) The role of nucleoside triphosphate hydrolase
metallochaperones in making metalloenzymes Metallomics 14, 10.1093/mtomcs/mfac030
44. Peterson, Y . K., Hazard, S., Graber, S. G., and Lanier, S. M. (2002) Identification of
structural features in the G-protein regulatory motif required for regulation of
heterotrimeric G-proteins J Biol Chem 277, 6767-6770 10.1074/jbc.C100699200
45. Winter, G. (2010) Xia2: an expert system for macromolecular crystallography data
reduction J Appl Crystallogr 43, 186-190 doi:10.1107/S0021889809045701
46. V onrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W. et al. (2011)
Data processing and analysis with the autoPROC toolbox Acta Crystallogr D Biol
Crystallogr 67, 293-302 10.1107/S0907444911007773
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint
Nucleotide promiscuity of FeoB
22
47. Adams, P. D., Afonine, P. V ., Bunkóczi, G., Chen, V . B., Davis, I. W., Echols, N. et al.
(2010) PHENIX: a comprehensive Python-based system for macromolecular structure
solution Acta Crystallogr D Biol Crystallogr 66, 213-221 10.1107/S0907444909052925
48. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O. et al. (2021)
Highly accurate protein structure prediction with AlphaFold Nature 596, 583-589
10.1038/s41586-021-03819-2
49. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics
Acta Crystallogr D, Biol Crystallogr 60, 2126-2132 10.1107/S0907444904019158
50. Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N. et
al. (2018) MolProbity: More and better reference data for improved all-atom structure
validation Protein Sci 27, 293-315 10.1002/pro.3330
51. Edgar, R. C. (2004) MUSCLE: multiple sequence alignment with high accuracy and high
throughput Nucleic Acids Res 32, 1792-1797 10.1093/nar/gkh340
52. Troshin, P. V ., Procter, J. B., and Barton, G. J. (2011) Java bioinformatics analysis web
services for multiple sequence alignment--JABAWS:MSA Bioinformatics 27, 2001-2002
10.1093/bioinformatics/btr304
53. Troshin, P. V ., Procter, J. B., Sherstnev, A., Barton, D. L., Madeira, F., and Barton, G. J.
(2018) JABAWS 2.2 distributed web services for Bioinformatics: protein disorder,
conservation and RNA secondary structure Bioinformatics 34, 1939-1940
10.1093/bioinformatics/bty045
54. Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M., and Barton, G. J. (2009)
Jalview Version 2--a multiple sequence alignment editor and analysis workbench
Bioinformatics 25, 1189-1191 10.1093/bioinformatics/btp033
55. Kumar, S., Stecher, G., Li, M., Knyaz, C., and Tamura, K. (2018) MEGA X: Molecular
Evolutionary Genetics Analysis across Computing Platforms Mol Biol Evol 35, 1547-
1549 10.1093/molbev/msy096
56. Stecher, G., Tamura, K., and Kumar, S. (2020) Molecular Evolutionary Genetics Analysis
(MEGA) for macOS Mol Biol Evol 37, 1237-1239 10.1093/molbev/msz312
57. Tamura, K., Stecher, G., and Kumar, S. (2021) MEGA11: Molecular Evolutionary
Genetics Analysis Version 11 Mol Biol Evol 38, 3022-3027 10.1093/molbev/msab120
58. Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A. et al. (2024) Accurate
structure prediction of biomolecular interactions with AlphaFold
/i13 Nature
10.1038/s41586-024-07487-w
59. Meng, E. C., Goddard, T. D., Pettersen, E. F., Couch, G. S., Pearson, Z. J., Morris, J. H. et
al. (2023) UCSF ChimeraX: Tools for structure building and analysis Protein Sci 32,
e4792 10.1002/pro.4792
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted May 22, 2024. ; https://doi.org/10.1101/2024.05.22.595361doi: bioRxiv preprint